866-997-4948(US-Canada Toll Free)

China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

Published By :

QYResearch

Published Date : Jun 2016

Category :

Cancer

No. of Pages : 152 Pages

The global Drugs for Treatment of Prostate Cancer market was valued at USD 30.41 Billion in 2015, and is projected to reach USD 35.26 Billion by 2021, at a CAGR of 59.49% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Prostate Cancer in China, Russia, Brazil and Japan market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer forecast to 2021, from 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 220ges, 231 charts and eight chapters, to display the market present situation and future, clearly and deeply.
 

Table of Contents

China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

1 Drugs for Treatment of Prostate Cancer Overview and Each Type
1.1 Product Overview of Prostate Cancer
1.1.1 Definition and Product Scope of Drugs for Prostate Cancer
1.1.2 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.3 Russia Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.4 Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.5 Japan Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List and of Each Type 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Triptorelin and Specification
1.2.5 Leuprorelin and Specification
1.2.6 Flutamide Tablets and Specification
1.2.7 Goserelin and Specification
1.2.8 Bicalutamide Tablets and Specification
1.2.9 Bicalutamide Capsules and Specification
1.2.10 Estramustine Phosphate Capsules and Specification
1.2.11 Mitoxantrone and Specification
1.2.12 Zytiga and Specification
1.2.13 Xtandi and Specification
1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4 Price List (Interviewed) of Goserelin by Manufacturers
1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers
1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9 Price List (Interviewed) of Zytiga by Manufacturers
1.3.10 Price List (Interviewed) of Xtandi by Manufacturers

2 Competition Analysis by Manufacturers in Global and China
2.1 Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.3 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.4 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.5 Russia Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.6 Russia Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.7 Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.8 Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.9 Brazil Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.10 Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.11 Japan Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.12 Japan Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.13 Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016

3 Sales and Revenue Segments of Each Type 2010 to 2015
3.1 China Sales and Revenue Segments of Each Type 2010 to 2015
3.1.1 China Sales and Market Share of Each Type 2010 to 2015
3.1.2 China Sales Growth Rate of Each Type 2015 to 2016
3.1.3 China Revenue and Market Share of Each Type 2015 to 2016
3.1.4 China Revenue and Market Share of Each Type 2015 to 2016
3.2 Russia Sales and Revenue Segments of Each Type 2015 to 2016
3.2.1 Russia Sales and Market Share of Each Type 2015 to 2016
3.2.2 Russia Sales Growth Rate of Each Type 2015 to 2016
3.2.3 Russia Revenue and Market Share of Each Type 2015 to 2016
3.2.4 Russia Revenue and Market Share of Each Type 2015 to 2016
3.3 Brazil Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Brazil Sales and Market Share of Each Type 2015 to 2016
3.3.2 Brazil Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.4 Japan Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Japan Sales and Market Share of Each Type 2015 to 2016
3.3.2 Japan Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Japan Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Japan Revenue and Market Share of Each Type 2015 to 2016

4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021

5 Raw Materials and Applications
5.1 Key Raw Materials and Price Analysis for Triptorelin
5.1.1 Key Raw Materials for Triptorelin
5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Leuprorelin
5.2.1 Key Raw Materials for Leuprorelin
5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Flutamide Tablets
5.3.1 Key Raw Materials for Flutamide Tablets
5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Goserelin
5.4.1 Key Raw Materials for Goserelin
5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets
5.5.1 Key Raw Materials for Bicalutamide Tablets
5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules
5.6.1 Key Raw Materials for Bicalutamide Capsules
5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules
5.7.1 Key Raw Materials for Estramustine Phosphate Capsules
5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Mitoxantrone
5.8.1 Key Raw Materials for Mitoxantrone
5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Zytiga
5.9.1 Key Raw Materials for Zytiga
5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Xtandi
5.10.1 Key Raw Materials for Xtandi
5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021
5.11 Applications of Triptorelin
5.12 Applications of Leuprorelin
5.13 Applications of Flutamide Tablets
5.14 Applications of Goserelin
5.15 Applications of Bicalutamide Tablets
5.16 Applications of Bicalutamide Capsules
5.17 Applications of Estramustine Phosphate Capsules
5.18 Applications of Mitoxantrone
5.19 Applications of Zytiga
5.20 Applications of Xtandi

6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer
6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact
6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact
6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact
6.6 Beijing Biote Pharmaceutical
6.6.1 Company Basic Information
6.6.2 Leuprorelin (Specification and Price)
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.4 Interviewee, Name and Contact
6.7 Livzon Pharmaceutical Group
6.7.1 Company Basic Information
6.7.2 Leuprorelin (Specification and Price)
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.4 Interviewee, Name and Contact
6.8 Schering-Plough Canada
6.8.1 Company Basic Information
6.8.2 Flutamide Tablets (Specification and Price)
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.4 Interviewee, Name and Contact
6. 9 JiangSu TASLY DI YI Pharmaceutical
6.9.1 Company Basic Information
6.9.2 Flutamide Tablets (Specification and Price)
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.4 Interviewee, Name and Contact
6.10 Shanghai Fudan Fuhua Pharmaceutical
6.10.1 Company Basic Information
6.10.2 Flutamide Tablets (Specification and Price)
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.4 Interviewee, Name and Contact
6.11 S.C.SINDAN-PHARMA S.R.L.
6.11.1 Company Basic Information
6.11.2 Flutamide Tablets (Specification and Price)
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.4 Interviewee, Name and Contact
6.12 AstraZeneca
6.12.1 Company Basic Information
6.12.2 Goserelin (Specification and Price)
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.4 Interviewee, Name and Contact
6.13 Corden Pharma GmbH
6.13.1 Company Basic Information
6.13.2 Bicalutamide Tablets (Specification and Price)
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.4 Interviewee, Name and Contact
6.14 Shanghai Zhaohui Pharmaceutical
6.14.1 Company Basic Information
6.14.2 Bicalutamide Tablets (Specification and Price)
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.4 Interviewee, Name and Contact
6.15 HISUN Pharmaceutical
6.15.1 Company Basic Information
6.15.2 Bicalutamide Tablets (Specification and Price)
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.4 Interviewee, Name and Contact
6.16 Shanxi Zhendong Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Bicalutamide Capsules (Specification and Price)
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.4 Interviewee, Name and Contact
6.17 Pfizer
6.17.1 Company Basic Information
6.17.2 Estramustine Phosphate Capsules (Specification and Price)
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.4 Interviewee, Name and Contact
6.18 Sichuan sunnyhope pharmaceutical
6.18.1 Company Basic Information
6.18.2 Mitoxantrone (Specification and Price)
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.4 Interviewee, Name and Contact
6.19 Luoxin Group
6.19.1 Company Basic Information
6.19.2 Mitoxantrone (Specification and Price)
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.4 Interviewee, Name and Contact
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Mitoxantrone (Specification and Price)
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.4 Interviewee, Name and Contact
6.21 JIANG SU HENG RUI MEDICINE
6.21.1 Company Basic Information
6.21.2 Mitoxantrone (Specification and Price)
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.4 Interviewee, Name and Contact
6.22 Johnson
6.22.1 Company Basic Information
6.22.2 Zytiga (Specification and Price)
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.4 Interviewee, Name and Contact
6.23 Astellas
6.23.1 Company Basic Information
6.23.2 Xtandi (Specification and Price)
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.4 Interviewee, Name and Contact

7 Technology Development Trend
7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend

8 Research Findings and Conclusion

List of Table

Figure Picture of Drugs for Prostate Cancer17
Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-202117
Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-202117
Figure Russia Market Size (Value) of Drugs for Prostate Cancer 2016-202117
Figure Russia Market Size (Volume) of Drugs for Prostate Cancer 2016-202118
Figure Brazil Market Size (Value) of Drugs for Prostate Cancer 2016-202118
Figure Brazil Market Size (Volume) of Drugs for Prostate Cancer 2016-202118
Figure Japan Market Size (Value) of Drugs for Prostate Cancer 2016-202118
Figure Japan Market Size (Volume) of Drugs for Prostate Cancer 2016-202118
Table Product Type of Key Manufacturers18
Table Price List and Forecast of Each Type19
Table Market Share of Each Type19
Figure Growth Rate of Each Type 2014 to 201520
Figure Picture of Triptorelin20
Table Specification of Triptorelin20
Figure Picture of Leuprorelin20
Table Specification of Leuprorelin20
Figure Picture of Flutamide Tablets21
Table Specification of Flutamide Tablets21
Figure Picture of Goserelin21
Table Specification of Goserelin21
Figure Picture of Bicalutamide Tablets21
Table Specification of Bicalutamide Tablets21
Figure Picture of Type Bicalutamide Capsules21
Table Specification of Type Bicalutamide Capsules21
Figure Picture of Estramustine Phosphate Capsules22
Table Specification of Estramustine Phosphate Capsules22
Figure Picture of Mitoxantrone22
Table Specification of Mitoxantrone22
Figure Picture of Zytiga22
Table Specification of Zytiga22
Figure Picture of Xtandi22
Table Specification of Xtandi23
Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 201623
Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 201623
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 201624
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 201624
Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 201625
Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 201625
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 201626
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 201626
Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 201627
Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 201627
Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 201628
Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 201628
Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 201529
Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 201529
Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 201530
Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 201530
Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 201631
Table Russia Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 201532
Table Russia Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 201532
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 201533
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 201533
Table Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 201634
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 201534
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 201535
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 201535
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 201536
Table Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 201636
Table Japan Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 201537
Table Japan Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 201537
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 201538
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 201539
Table Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 201639
Table China Sales of Each Type 2010 to 201540
Table China Sales Market Share of Each Type 2010 to 201540
Table China Sales Growth Rate of Each Type 2015 to 201640
Table China Revenue of Each Type 2015 to 201641
Table China Revenue Market Share of Each Type 2015 to 201641
Table China Revenue of Each Type 2015 to 201641
Table China Revenue Market Share of Each Type 2015 to 201642
Table Global Sales of Each Type 2015 to 201642
Table Russia Sales Market Share of Each Type 2015 to 201642
Table Global Sales Growth Rate of Each Type 2015 to 201642
Table Global Revenue of Each Type 2015 to 201643
Table Russia Revenue Market Share of Each Type 2015 to 201643
Table Russia Revenue of Each Type 2015 to 201643
Table Russia Revenue Market Share of Each Type 2015 to 201644
Table Brazil Sales of Each Type 2015 to 201644
Table Brazil Sales Market Share of Each Type 2015 to 201644
Table Brazil Sales Growth Rate of Each Type 2015 to 201645
Table Brazil Revenue of Each Type 2015 to 201645
Table Brazil Revenue Market Share of Each Type 2015 to 201645
Table Brazil Revenue of Each Type 2015 to 201645
Table Brazil Revenue Market Share of Each Type 2015 to 201646
Table Japan Sales of Each Type 2015 to 201646
Table Japan Sales Market Share of Each Type 2015 to 201646
Table Japan Sales Growth Rate of Each Type 2015 to 201647
Table Japan Revenue of Each Type 2015 to 201647
Table Japan Revenue Market Share of Each Type 2015 to 201647
Table Japan Revenue of Each Type 2015 to 201647
Table Japan Revenue Market Share of Each Type 2015 to 201648
Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-202149
Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 202150
Table Key Raw Materials for Triptorelin51
Table Price Forecast of Key Raw Materials for Triptorelin51
Table Key Raw Materials for Leuprorelin52
Table Price Forecast of Key Raw Materials for Leuprorelin52
Table Key Raw Materials for Flutamide Tablets52
Table Price Forecast of Key Raw Materials for Flutamide Tablets53
Table Key Raw Materials for Goserelin53
Table Price Forecast of Key Raw Materials for Goserelin53
Table Key Raw Materials for Bicalutamide Tablets54
Table Price Forecast of Key Raw Materials for Bicalutamide Tablets54
Table Key Raw Materials for Bicalutamide Capsules55
Table Price Forecast of Key Raw Materials for Bicalutamide Capsules55
Table Key Raw Materials for Estramustine Phosphate Capsules55
Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules56
Table Key Raw Materials for Mitoxantrone56
Table Price Forecast of Key Raw Materials for Mitoxantrone57
Table Key Raw Materials for Zytiga57
Table Price Forecast of Key Raw Materials for Zytiga57
Table Key Raw Materials for Xtandi58
Table Price Forecast of Key Raw Materials for Zytiga58
Table Applications of Triptorelin58
Table Applications of Leuprorelin59
Table Applications of Flutamide Tablets59
Table Applications of Goserelin59
Table Applications of Bicalutamide Tablets59
Table Applications of Bicalutamide Capsules60
Table Applications of Estramustine Phosphate Capsules60
Table Applications of Mitoxantrone60
Table Applications of Zytiga61
Table Applications of Xtandi61
Table IPSEN Basic Information List62
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of IPSEN62
Table Sales Value, Gross Margin and Growth rate of IPSEN in China62
Figure Product Sales Value, Growth rate of IPSEN in China63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Russia63
Figure Product Sales Value, Growth rate of IPSEN in Russia63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Brazil63
Figure Product Sales Value, Growth rate of IPSEN in Brazil63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Japan63
Figure Product Sales Value, Growth rate of IPSEN in Japan64
Table Ferring Pharmaceuticals Basic Information List64
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Ferring Pharmaceuticals64
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in China65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in China65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Russia65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Russia65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Brazil65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Brazil65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Japan66
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Japan66
Table Chengdu Tiantaishan pharmaceutical Basic Information List66
Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical in China67
Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical in China67
Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical in China67
Table GeneScience Pharmaceuticals Basic Information List67
Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals in China68
Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals in China68
Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals in China68
Table Takeda Pharmaceutical Company Limited Basic Information List69
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Takeda Pharmaceutical Company Limited69
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in China69
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in China70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Russia70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Russia70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Brazil70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Brazil70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Japan70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Japan71
Table Beijing Biote Pharmaceutical Basic Information List71
Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical in China71
Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical in China72
Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical in China72
Table Livzon Pharmaceutical Group Basic Information List72
Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group in China73
Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group in China73
Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group in China73
Table Schering-Plough Canada Basic Information List73
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Schering-Plough Canada74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in China74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in China74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Russia74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Russia75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Brazil75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Brazil75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Japan75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Japan75
Table JiangSu TASLY DI YI Pharmaceutical Basic Information List76
Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical in China76
Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical in China76
Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical in China77
Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List77
Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical in China77
Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China78
Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China78
Table S.C.SINDAN-PHARMA S.R.L. Basic Information List78
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of S.C.SINDAN-PHARMA S.R.L.79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in China79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in China79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil80
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan80
Table AstraZeneca Basic Information List80
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in China81
Figure Product Sales Value, Growth rate of AstraZeneca in China81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Russia81
Figure Product Sales Value, Growth rate of AstraZeneca in Russia82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Brazil82
Figure Product Sales Value, Growth rate of AstraZeneca in Brazil82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Japan82
Figure Product Sales Value, Growth rate of AstraZeneca in Japan82
Table Corden Pharma GmbH Basic Information List83
Table Specification, Price, Sales Value(China, Russia, Brazil and Japan)and Market Share of Corden Pharma GmbH83
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in China83
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in China84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Russia84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Russia84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Brazil84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Brazil84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Japan84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Japan85
Table Shanghai Zhaohui Pharmaceutical Basic Information List85
Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical in China85
Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical in China86
Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical in China86
Table HISUN Pharmaceutical Basic Information List86
Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical in China87
Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical in China87
Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical in China87
Table Shanxi Zhendong Pharmaceutical Basic Information List87
Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical in China88
Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical in China88
Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical in China88
Table Pfizer Basic Information List89
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer89
Table Sales Value, Gross Margin and Growth rate of Pfizer in China89
Figure Product Sales Value, Growth rate of Pfizer in China90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Russia90
Figure Product Sales Value, Growth rate of Pfizer in Russia90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Brazil90
Figure Product Sales Value, Growth rate of Pfizer in Brazil90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Japan90
Figure Product Sales Value, Growth rate of Pfizer in Japan90
Table Sichuan sunnyhope pharmaceutical Basic Information List91
Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical in China91
Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical in China91
Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical in China92
Table Luoxin Group Basic Information List92
Table Specification, Price, Sales Value and Market Share of Luoxin Group in China92
Table Sales Value, Gross Margin and Growth rate of Luoxin Group in China93
Figure Product Sales Value, Growth rate of Luoxin Group in China93
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List93
Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical in China94
Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical in China94
Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical94
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List94
Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE in China95
Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE China95
Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE in China95
Table Johnson Basic Information List96
Table Specification, Price, Sales Value and Market Share of Johnson in Japan96
Table Sales Value, Gross Margin and Growth rate of Johnson in Japan96
Figure Product Sales Value, Growth rate of Johnson in Japan96
Table Sales Value, Gross Margin and Growth rate of Johnson in Russia97
Figure Product Sales Value, Growth rate of Johnson in Russia97
Table Astellas Basic Information List97
Table Specification, Price, Sales Value and Market Share of Astellas in Japan97
Table Sales Value, Gross Margin and Growth rate of Astellas in Japan98
Figure Product Sales Value, Growth rate of Astellas in Japan98
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *